{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2000 Syphilis Screen"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K091361",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061247"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP"
    ],
    "Summary Letter Date": "December 16, 2009",
    "Summary Letter Received Date": "September 14, 2009",
    "Submission Date": "September 10, 2009",
    "Regulation Number(s)": [
        "21CFR866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Antibodies to Treponema pallidum"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE 2000 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE\u00ae 2000 Syphilis Screen chemiluminescent immunoassay for detection of Treponema pallidum antibodies",
    "Indications for Use Summary": "Qualitative detection of antibodies to Treponema pallidum in human serum or heparinized plasma as an aid in the diagnosis of syphilis, not intended for blood or plasma donor screening",
    "fda_folder": "Microbiology"
}